Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.

We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.

Download ChromeDownload Microsoft Edge
DBm-Health app
Sensyne Health | Healthcare

Remote monitoring for patients with, or at risk of diabetes

DBm-Health is a patient to clinician system that helps health care professionals manage patients with diabetes or at risk of diabetes, and promotes self-care.

It is ideally suited to patients needing additional support to maintain safe blood glucose levels.

Get it on Google PlayDownload on the App Store
The need for safe remote monitoring during the COVID-19 pandemic

The COVID-19 pandemic has increased the need for digital technologies to help clinicians manage their patients remotely, reducing the risk to individuals who are particularly vulnerable to COVID-19 and are advised to shield during the pandemic.


Patient communication

Frequent monitoring of readings and in-app messaging can facilitate improved communication and oversight.

Increased service capacity

Complex cases can be managed more efficiently, freeing up capacity for more patients without increasing resources.

Improved adherence

Easy-to-use apps can lead to more comprehensive reporting of blood glucose levels.

Improved reliability

Replaces paper-based processes which are associated with poor data reliability.

Faster audit

System reports replace time-consuming manual audit processes.

Support for self-monitoring

User-friendly displays of historical readings and self-help guides empower patients to self-manage their condition.

DBm-Health is classified as a Medical Device and is registered as such with the UK National Competent Authority (MHRA).

Download Product Guide

Free smartphone app

Patients can input and share blood glucose readings and other relevant data (i.e. medication taken), and request a callback from their care team.

Free smartphone app
Clinician's desktop app

Clinician's desktop app

Patient lists can be filtered to help prioritise interventions; individual blood glucose readings can be viewed; and messages sent to patients via the app or by SMS.

Self-monitoring for patients

Self-help guides and a record of blood glucose readings in diary and graph format helps patients to actively manage their blood glucose levels.

Self-management for patients
DBm-Health is intended for adult patients with, or at risk of diabetes needing frequent blood glucose monitoring, including:
  • Patients new to insulin treatment needing enhanced diabetes support from their healthcare team
  • Cancer patients receiving high dose steroid treatment
  • Women with diabetes planning a pregnancy
  • Patients with type 1 diabetes not suited to continuous glucose monitoring (CGM)
  • Patients with coronavirus at risk of hyperglycaemia
  • Patients with type 2 diabetes requiring intensive support


What is DBm-Health?
Who is DBm-Health intended for?
How do patients access and use the app?
How does the system help healthcare professionals and diabetes services?
How will DBm-Health help the NHS during and after the pandemic?
What are the main features of the app?
How much does DBm-Health cost? 
Does DBm-Health store any patient sensitive data?
What is the background to the development of DBm-Health?
Is there evidence to support the use of digital technologies for the management of blood glucose levels?
Does DBm-Health provide a patient diagnosis? 
Who can see the data entered into DBm-Health? 
What does anonymised data mean?
How do you protect personal and healthcare data? 
Who can patients contact with questions about their data?
1. 2019 surveillance of 4 diabetes guidelines – Consultation document. NICE ng28/update/ng28-update-1/documents/surveillance-review-proposal
2. Kebede MM, Zeeb H, Peters M, Heise TL, Pischke CR. Effectiveness of Digital Interventions for Improving Glycemic Control in Persons with Poorly Controlled Type 2 Diabetes: A Systematic Review, Meta-analysis, and Meta-regression Analysis. Diabetes Technol Ther. 2018;20(11):767-782. doi:10.1089/dia.2018.0216

Note: Not all Sensyne Health products are available in all territories, for further information contact head office.

Disclaimer: Sensyne Health are not responsible for external website content.